Jacobio Pharmaceuticals Group Co., Ltd.

OTCPK:JBPH.F Stock Report

Market Cap: US$189.7m

Jacobio Pharmaceuticals Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of JBPH.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,500,0001.07%
Employee Share Scheme48,862,2806.17%
Institutions50,893,6966.43%
Public Companies87,486,89011%
Individual Insiders153,789,47019.4%
VC/PE Firms189,970,89024%
General Public252,251,85431.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.6%
Yinxiang Wang
107,552,075US$25.8m0%no data
11.1%
Center Laboratories, Inc.
87,486,890US$21.0m0%no data
10.3%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
81,827,555US$19.6m0%1.99%
7.18%
Hillhouse Investment Management, Ltd.
56,861,110US$13.6m0%0.1%
6.48%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
51,282,225US$12.3m0%1.98%
3.86%
Willgenpharma LImited
30,590,000US$7.3m0%no data
2.94%
Yunyan Hu
23,292,295US$5.6m0%no data
2.9%
Xiaojie Wang
22,945,100US$5.5m-30.4%no data
2.31%
Gloryviewpharma Ltd
18,272,280US$4.4m0%no data
1.94%
E Fund Management Co., Ltd.
15,324,188US$3.7m0%0.01%
1.76%
The Vanguard Group, Inc.
13,903,800US$3.3m0.9%no data
1.07%
Blesspharma Ltd
8,500,000US$2.0m0%no data
0.88%
Bosera Asset Management Co., Ltd.
6,999,600US$1.7m0%0.01%
0.85%
GF Fund Management Co., Ltd.
6,738,600US$1.6m0%no data
0.21%
BlackRock, Inc.
1,701,300US$407.7k0.87%no data
0.11%
Orient Fund Management Co. Ltd.
896,700US$214.9k0%0.01%
0.11%
Oriental Alpha Fund Management Co., Ltd.
848,700US$203.4k0%0.02%
0.1%
Dimensional Fund Advisors LP
790,766US$189.5k-19.6%no data
0.087%
Guotai Asset Management Company Limited
687,600US$164.8k0%no data
0.061%
China Merchants Fund Management Company Ltd.
484,800US$116.2k0%no data
0.059%
China Universal Asset Management Company Ltd.
468,900US$112.4k0%no data
0.053%
State Street Global Advisors, Inc.
420,790US$100.9k-8.6%no data
0.047%
HuaAn Fund Management Company Ltd.
369,600US$88.6k0%no data
0.035%
Candriam
274,438US$65.8k0%no data
0.027%
HFT Investment Management Co. Ltd. (Group)
215,100US$51.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/19 19:44
End of Day Share Price 2024/02/20 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jacobio Pharmaceuticals Group Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyi ChenGoldman Sachs